Rivian Releases First Quarter 2026 Financial Results
- Started production of saleable R2 vehicles and made first deliveries to employees with external customer deliveries expected in the coming weeks
-
Consolidated revenue growth of 11 percent year-over-year and generated
of consolidated gross profit for the quarter$119 million -
Increased
Georgia plant initial production capacity to 300,000 vehicles annually; expects first advance on DOE loan in early 2027$4.5 billion - Robotaxi partnership with Uber to deploy up to 50,000 fully autonomous robotaxis
-
of funding from Volkswagen Group through successful completion of winter testing$1 billion
RJ Scaringe, Rivian Founder and CEO, said:
“With the launch of R2, we are excited to dramatically expand our market opportunity and have more people driving Rivians. The support of the Department of Energy for the
Business Highlights
Last week Rivian announced the start of production of saleable R2 vehicles in
The company made the strategic decision to increase the initial production capacity of its
As part of this new vision for the
In March, Rivian announced a partnership with Uber to help accelerate both companies’ autonomous vehicle plans. The deal is expected to enable Uber, or its fleet partners, to purchase 10,000 fully autonomous R2 robotaxis with the option to purchase up to 40,000 more in 2030. Uber will invest up to
Last month, Rivian’s joint venture with Volkswagen Group, Rivian and Volkswagen Group Technologies (RV Tech), successfully completed winter weather testing of its production-intent zonal architecture for first generation software-defined vehicles. Achieving this milestone unlocked a
First Quarter 2026 Results Summary
Production and Deliveries
-
10,236 vehicles produced at Rivian’s manufacturing facility in
Normal, Illinois . - 10,365 vehicles delivered to customers.
Revenues
-
Consolidated revenue was
, an 11 percent increase over the same quarter of the previous year.$1,381 million -
Automotive segment revenue was
, a 2 percent decrease over the same quarter of the previous year, primarily due to a$908 million decrease in sales of automotive regulatory credits and a decline in automotive revenue per unit delivered due to a higher mix of commercial vans, which were partially offset by a 20 percent increase in vehicle deliveries.$100 million -
Software and services segment revenue was
, a 49 percent increase over the same quarter of the previous year, due to an increase in vehicle electrical architecture and software development services, as well as vehicle repair and maintenance service and remarketing.$473 million
-
Automotive segment revenue was
Gross Profit
-
Consolidated gross profit was
, an$119 million decrease over the same quarter in the previous year.$87 million -
Automotive segment gross profit loss was
compared to$(62) million in gross profit for the same quarter in 2025, due primarily to the$92 million decrease in sales of automotive regulatory credits and lower production volumes, resulting in a$100 million and$42 million increase in depreciation and stock based compensation respectively.$3 million -
Software and services segment gross profit was
, a$181 million increase over the same quarter of the previous year, primarily due to higher vehicle electrical architecture and software development services and vehicle repair and maintenance services.$67 million
-
Automotive segment gross profit loss was
Operating Expenses and Operating Loss
-
Total operating expenses in the first quarter increased to
, compared to$1,000 million in the same quarter of the previous year. Within operating expenses, we recognized non-cash, stock-based compensation expenses of$861 million compared to$180 million in the same quarter of the previous year and depreciation and amortization expense of$159 million as compared to$80 million in the same quarter of the previous year.$72 million -
Research and development (R&D) expense was
compared to$458 million in the same quarter of the previous year. The increase was primarily related to increased software and cloud spend on autonomy and R2 pre-production costs, including payroll and related expenses.$381 million -
Selling, general and administrative (SG&A) expense was
compared to$542 million in the same quarter the previous year. The increase was primarily related to expanding our go-to-market operations and footprint, including higher payroll and stock-based compensation expenses and facilities, software, and other operating expenses.$480 million
-
Research and development (R&D) expense was
-
For the first quarter of 2026, we experienced a loss from operations of
compared to$881 million in the same quarter of the previous year due to lower gross profit and higher operating expenses.$655 million
Adjusted Operating Expenses
-
Total adjusted operating expenses for the first quarter of 2026 were
compared to$740 million for the same quarter of the previous year.$630 million -
Adjusted R&D expenses for the first quarter of 2026 were
compared to$348 million for the same quarter the previous year.$285 million -
Adjusted SG&A expenses for the first quarter of 2026 were
compared to$392 million for the same quarter the previous year.$345 million
-
Adjusted R&D expenses for the first quarter of 2026 were
Net Loss
-
Net loss for the first quarter of 2026 was
compared to$(416) million for the same quarter the previous year. Net loss for the quarter benefited from a$(541) million gain in other income related to the Series A capital raise and related deconsolidation of Mind Robotics.$506 million
Adjusted EBITDA
-
Adjusted EBITDA for the first quarter of 2026 was
compared to$(472) million for the same quarter the previous year.$(329) million
Net Cash Used in Operating Activities
-
Net cash used in operating activities for the first quarter of 2026 was
compared to$(703) million for the same quarter the previous year. The increase in net cash used in operations was primarily driven by cash consumed by working capital, increased operating expenses, and a reduction in regulatory credit sales.$(188) million
Capital Expenditures
-
Capital expenditures for the first quarter of 2026 were
compared to$372 million for the same quarter the previous year.$338 million
Liquidity and Free Cash Flow
-
Rivian ended the first quarter of 2026 with
in cash, cash equivalents, and short-term investments.$4,830 million -
Including the capacity under our asset-based revolving-credit facility, we ended the first quarter of 2026 with
of total liquidity.$5,394 million
-
Including the capacity under our asset-based revolving-credit facility, we ended the first quarter of 2026 with
-
We define free cash flow as net cash used or provided by operating activities less capital expenditures. The increase in net cash used in operating activities coupled with the increase in capital expenditures discussed above resulted in negative free cash flow¹ of
for the first quarter of 2026 compared to negative free cash flow of$(1,075) million for the same quarter the previous year.$(526) million
2026 Annual Guidance Summary
|
Current Outlook |
Vehicles Delivered |
62,000 - 67,000 |
Adjusted EBITDA |
|
Capital Expenditures |
|
Q1 2026 Results Webcast and Replay Information
Rivian will host an audio webcast to discuss its results and provide a business update at 2:00pm PT / 5:00pm ET on Thursday, April 30, 2026. The link to the webcast and shareholder presentation will be made available on the company’s Investor Relations website at rivian.com/investors. After the call, a replay will be available at rivian.com/investors for four weeks.
Quarterly Financial Performance (in millions, except production, delivery, and gross margin) (unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
|
|
March 31, 2025 |
|
June 30, 2025 |
|
September 30, 2025 |
|
December 31, 2025 |
|
March 31, 2026 |
||||||||||
Production |
|
|
14,611 |
|
|
|
5,979 |
|
|
|
10,720 |
|
|
|
10,974 |
|
|
|
10,236 |
|
Delivery |
|
|
8,640 |
|
|
|
10,661 |
|
|
|
13,201 |
|
|
|
9,745 |
|
|
|
10,365 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenues |
|
|
|
|
|
|
|
|
|
|
||||||||||
Automotive |
|
$ |
922 |
|
|
$ |
927 |
|
|
$ |
1,142 |
|
|
$ |
839 |
|
|
$ |
908 |
|
Software and services |
|
|
318 |
|
|
|
376 |
|
|
|
416 |
|
|
|
447 |
|
|
|
473 |
|
Total revenues |
|
$ |
1,240 |
|
|
$ |
1,303 |
|
|
$ |
1,558 |
|
|
$ |
1,286 |
|
|
$ |
1,381 |
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
||||||||||
Automotive |
|
$ |
830 |
|
|
$ |
1,262 |
|
|
$ |
1,272 |
|
|
$ |
898 |
|
|
$ |
970 |
|
Software and services |
|
|
204 |
|
|
|
247 |
|
|
|
262 |
|
|
|
268 |
|
|
|
292 |
|
Total cost of revenues |
|
$ |
1,034 |
|
|
$ |
1,509 |
|
|
$ |
1,534 |
|
|
$ |
1,166 |
|
|
$ |
1,262 |
|
Gross profit |
|
$ |
206 |
|
|
$ |
(206 |
) |
|
$ |
24 |
|
|
$ |
120 |
|
|
$ |
119 |
|
Gross margin |
|
|
17 |
% |
|
|
(16 |
)% |
|
|
2 |
% |
|
|
9 |
% |
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Research and development |
|
$ |
381 |
|
|
$ |
410 |
|
|
$ |
453 |
|
|
$ |
424 |
|
|
$ |
458 |
|
Selling, general, and administrative |
|
|
480 |
|
|
|
498 |
|
|
|
554 |
|
|
|
529 |
|
|
|
542 |
|
Total operating expenses |
|
$ |
861 |
|
|
$ |
908 |
|
|
$ |
1,007 |
|
|
$ |
953 |
|
|
$ |
1,000 |
|
Adjusted research and development (non-GAAP)¹ |
|
$ |
285 |
|
|
$ |
316 |
|
|
$ |
361 |
|
|
$ |
328 |
|
|
$ |
348 |
|
Adjusted selling, general, and administrative (non-GAAP)¹ |
|
|
345 |
|
|
|
365 |
|
|
|
422 |
|
|
|
384 |
|
|
|
392 |
|
Total adjusted operating expenses (non-GAAP)¹ |
|
$ |
630 |
|
|
$ |
681 |
|
|
$ |
783 |
|
|
$ |
712 |
|
|
$ |
740 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA (non-GAAP)1 |
|
$ |
(329 |
) |
|
$ |
(667 |
) |
|
$ |
(602 |
) |
|
$ |
(465 |
) |
|
$ |
(472 |
) |
Cash, cash equivalents, and short-term investments |
|
$ |
7,178 |
|
|
$ |
7,508 |
|
|
$ |
7,088 |
|
|
$ |
6,082 |
|
|
$ |
4,830 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash (used)/provided by operating activities |
|
$ |
(188 |
) |
|
$ |
64 |
|
|
$ |
26 |
|
|
$ |
(681 |
) |
|
$ |
(703 |
) |
Capital expenditures |
|
|
(338 |
) |
|
|
(462 |
) |
|
|
(447 |
) |
|
|
(463 |
) |
|
|
(372 |
) |
Free cash flow (non-GAAP)¹ |
|
$ |
(526 |
) |
|
$ |
(398 |
) |
|
$ |
(421 |
) |
|
$ |
(1,144 |
) |
|
$ |
(1,075 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization expense |
|
|
|
|
|
|
|
|
|
|
||||||||||
Cost of revenues |
|
$ |
75 |
|
|
$ |
185 |
|
|
$ |
125 |
|
|
$ |
108 |
|
|
$ |
122 |
|
Research and development |
|
|
17 |
|
|
|
17 |
|
|
|
18 |
|
|
|
20 |
|
|
|
23 |
|
Selling, general, and administrative |
|
|
55 |
|
|
|
52 |
|
|
|
55 |
|
|
|
59 |
|
|
|
57 |
|
Total depreciation and amortization expense |
|
$ |
147 |
|
|
$ |
254 |
|
|
$ |
198 |
|
|
$ |
187 |
|
|
$ |
202 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
||||||||||
Cost of revenues |
|
$ |
24 |
|
|
$ |
37 |
|
|
$ |
24 |
|
|
$ |
26 |
|
|
$ |
27 |
|
Research and development |
|
|
79 |
|
|
|
77 |
|
|
|
74 |
|
|
|
76 |
|
|
|
87 |
|
Selling, general, and administrative |
|
|
80 |
|
|
|
81 |
|
|
|
77 |
|
|
|
86 |
|
|
|
93 |
|
Total stock-based compensation expense |
|
$ |
183 |
|
|
$ |
195 |
|
|
$ |
175 |
|
|
$ |
188 |
|
|
$ |
207 |
|
¹A reconciliation of non-GAAP financial measures to the most comparable GAAP measure is provided later in this presentation. |
||||||||||||||||||||
Condensed Consolidated Balance Sheets1 (in millions, except per share amounts) (unaudited) |
||||||||
Assets |
|
December 31, 2025 |
|
March 31, 2026 |
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
3,579 |
|
|
$ |
2,845 |
|
Short-term investments |
|
|
2,503 |
|
|
|
1,985 |
|
Accounts receivable, net |
|
|
555 |
|
|
|
342 |
|
Inventory |
|
|
1,594 |
|
|
|
1,543 |
|
Other current assets |
|
|
361 |
|
|
|
330 |
|
Total current assets |
|
|
8,592 |
|
|
|
7,045 |
|
Property, plant, and equipment, net |
|
|
5,119 |
|
|
|
5,434 |
|
Operating lease assets, net |
|
|
571 |
|
|
|
601 |
|
Strategic investments |
|
|
119 |
|
|
|
669 |
|
Other non-current assets |
|
|
463 |
|
|
|
484 |
|
Total assets |
|
$ |
14,864 |
|
|
$ |
14,233 |
|
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
595 |
|
|
$ |
754 |
|
Accrued liabilities |
|
|
1,438 |
|
|
|
1,045 |
|
Current portion of deferred revenues, lease liabilities, and other liabilities |
|
|
1,660 |
|
|
|
1,554 |
|
Total current liabilities |
|
|
3,693 |
|
|
|
3,353 |
|
Long-term debt |
|
|
4,440 |
|
|
|
4,442 |
|
Non-current lease liabilities |
|
|
551 |
|
|
|
580 |
|
Other non-current liabilities |
|
|
1,586 |
|
|
|
1,429 |
|
Total liabilities |
|
|
10,270 |
|
|
|
9,804 |
|
Commitments and contingencies |
|
|
|
|
||||
Stockholders' equity: |
|
|
|
|
||||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
1 |
|
|
|
1 |
|
Additional paid-in capital |
|
|
31,508 |
|
|
|
31,767 |
|
Accumulated deficit |
|
|
(26,951 |
) |
|
|
(27,367 |
) |
Accumulated other comprehensive income |
|
|
8 |
|
|
|
2 |
|
Noncontrolling interest |
|
|
28 |
|
|
|
26 |
|
Total stockholders' equity |
|
|
4,594 |
|
|
|
4,429 |
|
|
|
|
|
|
||||
Total liabilities and stockholders' equity |
|
$ |
14,864 |
|
|
$ |
14,233 |
|
1 The prior period has been recast to conform to current period presentation. |
|
|
|
|
||||
Condensed Consolidated Statements of Operations (in millions, except per share amounts) (unaudited) |
||||||||
|
|
Three Months Ended March 31, |
||||||
|
|
|
2025 |
|
|
|
2026 |
|
Automotive |
|
$ |
922 |
|
|
$ |
908 |
|
Software and services |
|
|
318 |
|
|
|
473 |
|
Total revenues |
|
|
1,240 |
|
|
|
1,381 |
|
Automotive |
|
|
830 |
|
|
|
970 |
|
Software and services |
|
|
204 |
|
|
|
292 |
|
Total cost of revenues |
|
|
1,034 |
|
|
|
1,262 |
|
Gross profit |
|
|
206 |
|
|
|
119 |
|
Operating expenses |
|
|
|
|
||||
Research and development |
|
|
381 |
|
|
|
458 |
|
Selling, general, and administrative |
|
|
480 |
|
|
|
542 |
|
Total operating expenses |
|
|
861 |
|
|
|
1,000 |
|
Loss from operations |
|
|
(655 |
) |
|
|
(881 |
) |
Interest income |
|
|
81 |
|
|
|
50 |
|
Interest expense |
|
|
(72 |
) |
|
|
(65 |
) |
Other income, net1 |
|
|
107 |
|
|
|
478 |
|
Loss before income taxes |
|
|
(539 |
) |
|
|
(418 |
) |
Provision for income taxes |
|
|
(2 |
) |
|
|
2 |
|
Net loss |
|
|
(541 |
) |
|
|
(416 |
) |
Less: Net income attributable to noncontrolling interest |
|
|
4 |
|
|
|
— |
|
Net loss attributable to common stockholders |
|
$ |
(545 |
) |
|
$ |
(416 |
) |
Net loss attributable to common stockholders, basic and diluted |
|
$ |
(545 |
) |
|
$ |
(416 |
) |
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted |
|
$ |
(0.48 |
) |
|
$ |
(0.33 |
) |
Weighted-average common shares outstanding, basic and diluted |
|
|
1,137 |
|
|
|
1,249 |
|
1 During the quarter ended March 31, 2026, we recognized a |
||||||||
Condensed Consolidated Statements of Cash Flows1 (in millions) (unaudited) |
||||||||
|
|
Three Months Ended March 31, |
||||||
|
|
|
2025 |
|
|
|
2026 |
|
Cash flows from operating activities: |
|
|
|
|
||||
Net loss |
|
$ |
(541 |
) |
|
$ |
(416 |
) |
Depreciation and amortization |
|
|
200 |
|
|
|
194 |
|
Stock-based compensation expense |
|
|
188 |
|
|
|
207 |
|
Gain on strategic investments |
|
|
(101 |
) |
|
|
(506 |
) |
Other non-cash activities |
|
|
20 |
|
|
|
74 |
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable, net |
|
|
31 |
|
|
|
211 |
|
Inventory |
|
|
(364 |
) |
|
|
(80 |
) |
Other assets |
|
|
14 |
|
|
|
89 |
|
Accounts payable and accrued liabilities |
|
|
334 |
|
|
|
(182 |
) |
Deferred revenues |
|
|
59 |
|
|
|
(290 |
) |
Other liabilities |
|
|
(28 |
) |
|
|
(4 |
) |
Net cash used in operating activities |
|
|
(188 |
) |
|
|
(703 |
) |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
|
||||
Purchases of equity securities and short-term investments |
|
|
(835 |
) |
|
|
(558 |
) |
Sales of equity securities and short-term investments |
|
|
48 |
|
|
|
16 |
|
Maturities of short-term investments |
|
|
717 |
|
|
|
1,003 |
|
Deconsolidation of Mind Robotics, Inc. |
|
|
— |
|
|
|
(114 |
) |
Capital expenditures |
|
|
(338 |
) |
|
|
(372 |
) |
Net cash used in investing activities |
|
|
(408 |
) |
|
|
(25 |
) |
|
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
|
||||
Proceeds from stock-based compensation programs |
|
|
2 |
|
|
|
1 |
|
Other financing activities |
|
|
(8 |
) |
|
|
(3 |
) |
Net cash used in financing activities |
|
|
(6 |
) |
|
|
(2 |
) |
|
|
|
|
|
||||
Effect of exchange rate changes on cash and cash equivalents |
|
|
1 |
|
|
|
(4 |
) |
Net change in cash |
|
|
(601 |
) |
|
|
(734 |
) |
Cash, cash equivalents, and restricted cash—Beginning of period |
|
|
5,294 |
|
|
|
3,579 |
|
Cash, cash equivalents, and restricted cash—End of period |
|
$ |
4,693 |
|
|
$ |
2,845 |
|
|
|
|
|
|
||||
Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
|
||||
Capital expenditures included in liabilities |
|
$ |
423 |
|
|
$ |
534 |
|
Capital stock issued to settle bonuses |
|
$ |
47 |
|
|
$ |
110 |
|
Right-of-use assets obtained in exchange for operating lease liabilities |
|
$ |
73 |
|
|
$ |
60 |
|
1 The prior period has been recast to conform to current period presentation. |
||||||||
|
||||||||
Reconciliation of Non-GAAP Financial Measures (in millions) (unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
|
|
March 31, 2025 |
|
June 30, 2025 |
|
September 30, 2025 |
|
December 31, 2025 |
|
March 31, 2026 |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted Research and Development Expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
Total research and development expenses |
|
$ |
381 |
|
|
$ |
410 |
|
|
$ |
453 |
|
|
$ |
424 |
|
|
$ |
458 |
|
R&D depreciation and amortization expenses |
|
|
(17 |
) |
|
|
(17 |
) |
|
|
(18 |
) |
|
|
(20 |
) |
|
|
(23 |
) |
R&D stock-based compensation expenses |
|
|
(79 |
) |
|
|
(77 |
) |
|
|
(74 |
) |
|
|
(76 |
) |
|
|
(87 |
) |
Adjusted research and development (non-GAAP) |
|
$ |
285 |
|
|
$ |
316 |
|
|
$ |
361 |
|
|
$ |
328 |
|
|
$ |
348 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted Selling, General, and Administrative Expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
Total selling, general, and administrative expenses |
|
$ |
480 |
|
|
$ |
498 |
|
|
$ |
554 |
|
|
$ |
529 |
|
|
$ |
542 |
|
SG&A depreciation and amortization expenses |
|
|
(55 |
) |
|
|
(52 |
) |
|
|
(55 |
) |
|
|
(59 |
) |
|
|
(57 |
) |
SG&A stock-based compensation expenses |
|
|
(80 |
) |
|
|
(81 |
) |
|
|
(77 |
) |
|
|
(86 |
) |
|
|
(93 |
) |
Adjusted selling, general, and administrative (non-GAAP) |
|
$ |
345 |
|
|
$ |
365 |
|
|
$ |
422 |
|
|
$ |
384 |
|
|
$ |
392 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted Operating Expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
Total operating expenses |
|
$ |
861 |
|
|
$ |
908 |
|
|
$ |
1,007 |
|
|
$ |
953 |
|
|
$ |
1,000 |
|
R&D depreciation and amortization expenses |
|
|
(17 |
) |
|
|
(17 |
) |
|
|
(18 |
) |
|
|
(20 |
) |
|
|
(23 |
) |
R&D stock-based compensation expenses |
|
|
(79 |
) |
|
|
(77 |
) |
|
|
(74 |
) |
|
|
(76 |
) |
|
|
(87 |
) |
SG&A depreciation and amortization expenses |
|
|
(55 |
) |
|
|
(52 |
) |
|
|
(55 |
) |
|
|
(59 |
) |
|
|
(57 |
) |
SG&A stock-based compensation expenses |
|
|
(80 |
) |
|
|
(81 |
) |
|
|
(77 |
) |
|
|
(86 |
) |
|
|
(93 |
) |
Total adjusted operating expenses (non-GAAP) |
|
$ |
630 |
|
|
$ |
681 |
|
|
$ |
783 |
|
|
$ |
712 |
|
|
$ |
740 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
||||||||||
Net loss attributable to common stockholders |
|
$ |
(545 |
) |
|
$ |
(1,117 |
) |
|
$ |
(1,173 |
) |
|
$ |
(811 |
) |
|
$ |
(416 |
) |
Interest income, net |
|
|
(9 |
) |
|
|
(3 |
) |
|
|
(7 |
) |
|
|
— |
|
|
|
15 |
|
Provision for income taxes |
|
|
2 |
|
|
|
2 |
|
|
|
(1 |
) |
|
|
3 |
|
|
|
(2 |
) |
Depreciation and amortization |
|
|
147 |
|
|
|
254 |
|
|
|
198 |
|
|
|
187 |
|
|
|
202 |
|
Stock-based compensation expense |
|
|
183 |
|
|
|
195 |
|
|
|
175 |
|
|
|
188 |
|
|
|
207 |
|
Other (income) expense, net1 |
|
|
(107 |
) |
|
|
2 |
|
|
|
191 |
|
|
|
(32 |
) |
|
|
(478 |
) |
Restructuring expenses |
|
|
— |
|
|
|
— |
|
|
|
15 |
|
|
|
— |
|
|
|
— |
|
Adjusted EBITDA (non-GAAP) |
|
$ |
(329 |
) |
|
$ |
(667 |
) |
|
$ |
(602 |
) |
|
$ |
(465 |
) |
|
$ |
(472 |
) |
1 During the quarter ended March 31, 2026, we recognized a |
||||||||||||||||||||
Quarterly Financial Performance Reconciliation of Non-GAAP Financial Measures Continued (in millions) (unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
|
|
March 31,
|
|
June 30,
|
|
September 30,
|
|
December 31,
|
|
March 31,
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Free Cash Flow |
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash (used)/provided by operating activities |
|
|
(188 |
) |
|
|
64 |
|
|
|
26 |
|
|
|
(681 |
) |
|
|
(703 |
) |
Capital expenditures |
|
|
(338 |
) |
|
|
(462 |
) |
|
|
(447 |
) |
|
|
(463 |
) |
|
|
(372 |
) |
Free cash flow (non-GAAP) |
|
$ |
(526 |
) |
|
$ |
(398 |
) |
|
$ |
(421 |
) |
|
$ |
(1,144 |
) |
|
$ |
(1,075 |
) |
Forward Looking Statements:
This press release and statements that are made on our earnings call contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release and made on our earnings call that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations, initiatives and business strategy, including our future financial results, vehicle profitability and future gross profits, our future capital expenditures, the underlying trends in our business (including customer preferences and expectation), macroeconomic and policy conditions, including changes to the availability of government and economic incentives, including tax credits, for electric vehicles, our market opportunity, and our potential for growth, our production ramp and manufacturing capacity expansion and anticipated production levels, the timeline for the start of production at the
*Non-GAAP Financial Measures
In addition to our results determined in accordance with generally accepted accounting principles in
Our non-GAAP financial measures include adjusted research and development expenses, adjusted selling, general, and administrative expenses, adjusted EBITDA, and free cash flow.
Adjusted research and development expenses is defined as total research and development expenses, less R&D depreciation and amortization expenses and R&D stock-based compensation expenses.
Adjusted selling, general, and administrative expenses is defined as total selling, general, and administrative expenses, less SG&A depreciation and amortization expenses and SG&A stock-based compensation expenses.
Adjusted EBITDA defined as net loss before interest expense (income), net, provision for income taxes, depreciation and amortization, stock-based compensation, other (expense) income, net, and special items. Our management team ordinarily excludes special items from its review of the results of the ongoing operations. Special items is comprised of (i) cost of revenue efficiency initiatives which include costs incurred as we transition between major vehicle programs, cost incurred for negotiations with major suppliers regarding changing demand forecasts or design modifications, and other costs for enhancing capital and cost optimization of the Company (ii) restructuring expenses for significant actions taken by the Company, (iii) significant asset impairments and write-offs, and (iv) other items that we do not necessarily consider to be indicative of earnings from ongoing operating activities, including loss (gain) on convertible note, net, and joint venture formation expenses.
Free cash flow is defined as net cash used in operating activities less capital expenditures.
About Rivian:
Rivian (NASDAQ: RIVN) is an American automotive technology company that develops and manufactures category-defining electric vehicles as well as vertically integrated technologies and services. Through innovation across its electrical architecture, end-to-end software, autonomous driving platform, artificial intelligence, and propulsion, the company creates vehicles that excel at work and play with the goal of accelerating the global transition to zero-emission transportation and energy. Rivian vehicles are manufactured in
View source version on businesswire.com: https://www.businesswire.com/news/home/20260430946068/en/
Investors: ir@rivian.com
Media: Harry Porter, media@rivian.com
Source: Rivian